UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2401
Option Care Health
OPCH
$4.74B
| $26.4M | ﹤0.01% |
1,260,195
+449,684
| +55% | +$10.5M |
2014 Q4
46 quarters
|
|
2402
Dana Inc
DAN
$2.19B
| $26.4M | ﹤0.01% |
971,191
-517,244
| -35% | -$17.7M |
2014 Q4
46 quarters
|
|
2403
Genmab
GMAB
$32.8B
| $26.4M | ﹤0.01% |
961,053
+662,921
| +222% | +$17.6M |
2019 Q3
27 quarters
|
|
2404
Cinemark Holdings
CNK
$4.5B
| $26.4M | ﹤0.01% |
831,672
-466,716
| -36% | -$13.9M |
2014 Q4
46 quarters
|
|
2405
PUT
Nextpower Inc. Common Stock
NXT
$15B
| $26.4M | ﹤0.01% |
+221,400
| New | +$27.3M |
2026 Q2
0 quarters
|
|
2406
Invesco S&P 500 Pure Growth ETF
RPG
$1.62B
| $26.4M | ﹤0.01% |
412,807
-68,099
| -14% | -$3.87M |
2014 Q4
46 quarters
|
|
2407
Viridian Therapeutics
VRDN
$3.3B
| $26.2M | ﹤0.01% |
1,428,843
+1,121,709
| +365% | +$18.1M |
2017 Q2
36 quarters
|
|
2408
Kanzhun
BZ
$7.66B
| $26.2M | ﹤0.01% |
2,036,243
-766,773
| -27% | -$10.5M |
2021 Q2
20 quarters
|
|
2409
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$4B
| $26.2M | ﹤0.01% |
169,700
-421,700
| -71% | -$70.6M |
2014 Q4
46 quarters
|
|
2410
Fluence Energy
FLNC
$733M
| $26.2M | ﹤0.01% |
1,315,427
+71,532
| +6% | +$1.33M |
2021 Q4
18 quarters
|
|
2411
SOLV Energy Inc
MWH
$5.02B
| $26.1M | ﹤0.01% |
767,550
+482,693
| +169% | +$17.5M |
2026 Q1
1 quarter
|
|
2412
PUT
Vertex Pharmaceuticals
VRTX
$139B
| $26M | ﹤0.01% |
52,400
-14,600
| -22% | -$6.47M |
2023 Q1
13 quarters
|
|
2413
Eagle Materials
EXP
$5.74B
| $26M | ﹤0.01% |
115,401
+23,672
| +26% | +$4.95M |
2014 Q4
46 quarters
|
|
|
OGG
2414
Osisko Gold Group
OGG
$812M
| $26M | ﹤0.01% |
10,549,391
+10,308,084
| +4,272% | +$30.6M |
2022 Q4
14 quarters
|
|
2415
PUT
Intuitive Surgical
ISRG
$161B
| $25.9M | ﹤0.01% |
65,200
-23,900
| -27% | -$10.4M |
2019 Q2
28 quarters
|
|
2416
Reinsurance Group of America
RGA
$17.6B
| $25.9M | ﹤0.01% |
121,686
-44,403
| -27% | -$9.26M |
2014 Q4
46 quarters
|
|
2417
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.47B
| $25.9M | ﹤0.01% |
551,360
+40,979
| +8% | +$1.84M |
2015 Q1
45 quarters
|
|
2418
Enovis
ENOV
$1.56B
| $25.8M | ﹤0.01% |
1,247,409
+425,503
| +52% | +$10M |
2014 Q4
46 quarters
|
|
2419
Robert Half
RHI
$4.33B
| $25.8M | ﹤0.01% |
840,570
-605,691
| -42% | -$17M |
2014 Q4
46 quarters
|
|
2420
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.55B
| $25.8M | ﹤0.01% |
184,252
-82
| -0% | -$10.8K |
2014 Q4
46 quarters
|
|
2421
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.15B
| $25.8M | ﹤0.01% |
443,180
+258,656
| +140% | +$16.2M |
2014 Q4
46 quarters
|
|
2422
PUT
Wynn Resorts
WYNN
$8.54B
| $25.7M | ﹤0.01% |
265,100
-244,000
| -48% | -$25.2M |
2014 Q4
46 quarters
|
|
2423
Globant
GLOB
$2.04B
| $25.7M | ﹤0.01% |
889,313
+491,449
| +124% | +$19.6M |
2014 Q4
46 quarters
|
|
2424
TransAlta
TAC
$4.15B
| $25.7M | ﹤0.01% |
1,858,480
+39,504
| +2% | +$522K |
2021 Q4
18 quarters
|
|
2425
Ingram Micro Holding
INGM
$5.81B
| $25.7M | ﹤0.01% |
936,164
+443,153
| +90% | +$12.4M |
2024 Q4
6 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.